Palmitic Acid

Palmitic Acid

SCHEMBL28867355

CCCCCCCCCCCCCCCC(=O)O.CCCCCOCC(O)COP(=O)(O)O.NC(CO)C(=O)O

nearest known ligand 0.65

Full drug profile on Sugi Atlas →

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
LPAR5 Q9H1C0 4/20 0.65
P2RY10 O00398 9/20 0.60
GPR174 Q9BXC1 6/20 0.53
GPR34 Q9UPC5 5/20 0.53
LPAR1 Q92633 8/20 0.52
LPAR3 Q9UBY5 5/20 0.52
LPAR4 Q99677 3/20 0.52
LPAR2 Q9HBW0 3/20 0.52
ENPP2 Q13822 3/20 0.52
LPAR6 P43657 2/20 0.52
CES2 O00748 1/20 0.47
TRPV1 Q8NER1 1/20 0.47
USP2 O75604 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Serine SCHEMBL28305481 0.94 LPAR5 (0.73) LPAR5P2RY10GPR174GPR34LPAR1
Palmitic Acid SCHEMBL28322662 0.90 LPAR5 (0.73) LPAR5P2RY10LPAR1LPAR3LPAR4
Serine SCHEMBL27966438 0.88 LPAR1 (0.66) LPAR5P2RY10GPR34LPAR1LPAR3
Serine SCHEMBL28122406 0.83 LPAR1 (0.77) LPAR5P2RY10GPR174GPR34LPAR1
Serine SCHEMBL28261903 0.83 LPAR1 (0.77) LPAR5P2RY10GPR174GPR34LPAR1
Serine SCHEMBL27997070 0.82 LPAR1 (0.74) LPAR5P2RY10LPAR1LPAR3LPAR4
Serine SCHEMBL28869167 0.82 LPAR1 (0.74) LPAR5P2RY10LPAR1LPAR3LPAR4
Glycerin SCHEMBL28131472 0.81 LPAR5 (0.88) LPAR5P2RY10LPAR1LPAR3LPAR4
Alcohol SCHEMBL27989503 0.81 LPAR5 (0.94) LPAR5P2RY10LPAR1LPAR3LPAR4
SCHEMBL7820593 0.81 LPAR5 (1.00) LPAR5P2RY10LPAR1LPAR3LPAR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109071527-A Cellular signal transduction inhibitor, their preparation and its method 成事在人肿瘤学公司 2018-12-21 CN disclosed